Aug 12, 2025 | Knowledge Hub
PathCare introduces Xpert MTB/XDR testing as a reflex test for rapid molecular drug susceptibility testing of rifampicin-resistant Mycobacterium tuberculosis (RR-TB) positive clinical samples South Africa remains one of the top 30 high-burden countries for...
Aug 12, 2025 | Knowledge Hub
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during July 2025 (epidemiological weeks 27-31). The data is dependent on submission of samples by clinicians and therefore may not be...
Aug 12, 2025 | Knowledge Hub
We are pleased to announce an important enhancement to our endocrine diagnostics service. As of 29 July 2025, our laboratory will transition from reporting urine total (deconjugated) metanephrines (currently performed via HPLC) to urine free (unconjugated)...
Aug 4, 2025 | Knowledge Hub
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare Laboratories during June 2025. Respiratory Pathogen Statistics June 2025 View...
Aug 4, 2025 | Knowledge Hub
PathCare has developed a unique reporting tool which consolidates pathology results for diabetic patients. This report allows healthcare providers to assess diabetes management performance of their patient as a group, as well as at an individual level. The Diabetes...
